The evolving landscape of antiemetic prophylaxis for chemotherapy-induced nausea and vomiting: inspiration from cisplatin-based antiemetic and non-antiemetic trials
The landscape of CINV management in cisplatin-based chemotherapy has evolved significantly alongside improvements in antiemetic agents. Substantial progress has been made in emesis control within both antiemetic and non-antiemetic cisplatin-based clinical trials. More attention should be paid on the chemotherapy induced nausea, and multiple approaches are needed to increase guideline adherence in future clinical practice.
Authors
- Yaxiong Zhang (ORCID: https://orcid.org/0009-0001-9880-3834)
- Xi Chen (ORCID: https://orcid.org/0000-0002-0178-720X)
- Gang Chen (ORCID: https://orcid.org/0000-0002-2378-6056)
- Li Zhang (ORCID: https://orcid.org/0000-0003-0595-0761)
- Yalan Wang (ORCID: https://orcid.org/0000-0001-5252-7259)
- Ya Sun
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1007/s00520-024-09035-8
- Citations
- 1
- Primary Topic
- Nausea and vomiting management
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- National Key Research and Development Program of China
- Science and Technology Planning Project of Guangdong Province